Psychiatry and Neurology, Neurology · Coeur D Alene, ID
NPI
1932596970
Since 2015
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
700 W Ironwood Dr Ste 158
Coeur D Alene, ID, 83814
Phone (208) 625-5100
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,522 services
Medicare patients, 2024
361
Average age 75
Drug cost, 2024
$947K
2,890 prescriptions
Company payments, 2025
$468
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angela Pana was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 456 times for 244 patients. In total Angela Pana billed 1,522 services in 22 codes, and Medicare paid $82K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 456 | 244 | $11.78 | $5,372 |
| 99215 Office E&M - Established | Facility | 281 | 184 | $96.72 | $27K |
| 99214 Office E&M - Established | Facility | 219 | 160 | $69.08 | $15K |
| 95983 Electrical Nerve Conductivity | Facility | 107 | 46 | $34.80 | $3,724 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 92 | 61 | $22.21 | $2,043 |
| 99205 Office E&M - New | Facility | 71 | 71 | $132.16 | $9,383 |
| 64616 Musculoskeletal | Facility | 59 | 18 | $103.93 | $6,132 |
| 99213 Office E&M - Established | Facility | 39 | 33 | $45.31 | $1,767 |
| 95984 Electrical Nerve Conductivity | Facility | 33 | 19 | $28.70 | $947 |
By year: 2022 $56K for 1,136 services; 2023 $84K for 1,227 services; 2024 $82K for 1,522 services.
Medicare prescription drug claims, 2024
In 2024, the drug Angela Pana prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 749 prescriptions and refills. In total Angela Pana wrote 2,890 Medicare prescriptions that cost $947K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 749 | 1,662 | 197 | $21K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 309 | 686 | 94 | $18K |
| Rytary Carbidopa/Levodopa | 195 | 245 | 30 | $257K |
| Clonazepam Generic | 177 | 237 | 28 | $1,732 |
| Primidone Generic | 133 | 262 | 25 | $2,344 |
| Gabapentin Generic | 119 | 256 | 33 | $1,764 |
| Amantadine Amantadine Hcl | 104 | 190 | 29 | $8,026 |
| Rasagiline Mesylate Generic | 100 | 179 | 25 | $19K |
| Propranolol Hcl Generic | 93 | 163 | 27 | $3,773 |
| Botox Onabotulinumtoxina | 89 | 247 | 29 | $115K |
| Donepezil Hcl Generic | 67 | 127 | 17 | $461 |
| Selegiline Hcl Generic | 52 | 100 | 15 | $6,504 |
| Propranolol Hcl Er Propranolol Hcl | 51 | 101 | 12 | $1,965 |
| Baclofen Generic | 50 | 72 | Under 11 | $730 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 47 | 85 | Under 11 | $901 |
Brand drugs: 506 claims; generic drugs: 2,384 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angela Pana $468 ($468 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $348.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.